Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Innovation & Technologie Angebot

Culture and enrichment method, medium and maintenance of cancer stem cells

Country of Origin: Spain
Reference Number: TOES20190401003
Publication Date: 4 April 2019

Summary

A Spanish hospital research group has developed a cell culture medium suitable for the isolation and/or enrichment of cancerous stem cells (CSCs). This technology does not require previous manipulation of cells and it is serum free. The research group is seeking to establish a licensing agreement or an agreement of a public-private partnership in order to further develop the technology (technical cooperation agreement).

Description

Cancer is, after heart disease, the second most common cause of death in the developed countries nowadays. Cancer stem cells (CSCs) are cancer cells (found within tumors) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.

A Spanish research group from the public health service, whose field of activity is, among others, medical oncology, supported by two universities, has developed a cell culture medium for isolating and/or enriching cancer stem cells, produced by culturing of mesenchymal stem cells in a conventional serum-free medium.

The patented technology consists in sowing, in the previous conditioned medium, a sample containing CSCs, and producing the cell population, with the additional characteristic that, before culturing the CSCs in the conditional medium, the culture is treated with diluted trypsin, and the cells, which are sensitive to trypsin and have a higher percentage of CSCs, are isolated.

The technology is serum free, which promotes the in vitro proliferation and conservation of pluripotency potential which allows to maintain an undifferentiated state of cancer stem cells subpopulation and at the same time does not allow the survival of differentiated cells.

The group is looking for the following collaboration:
-License agreement, in the framework of authorizing the interested parties to use the technology.
-Technical cooperation agreement, to collaborate with other research teams, companies or foundations.

Advantages and Innovations

- Serum-free conditioned medium that does not require prior manipulation of cells. 
- Efficient enrichment method of cancer stem cells (CSCs), as well as obtaining a population basically pure of CSCs.

Stage Of Development

Available for demonstration

Requested partner

The research group aims to formalize a technology transfer process with entities interested in the implementation of the solution, through a license agreement. 

If there are some entities, such as R&D centres, technology centres or specialized companies, interested in collaborating and developing further aspects of the solution, a technical cooperation agreement could be envisaged.

Kooperationsanfrage stellen